A synthetic peptide for use as a blocking control in assays to test for specificity of TKT antibody, Alternative Names: TKT control peptide, TKT antibody Blocking Peptide, Anti-TKT Blocking Peptide, Transketolase Blocking Peptide, Wernicke-Korsakoff Syndrome Blocking Peptide, FLJ34765 Blocking Peptide, TKT1 Blocking Peptide
TKT
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
TKT
(Transketolase (TKT))
Hintergrund
TKT belongs to the transketolase family. TKT has been implicated in the latent genetic disease Wernicke-Korsakoff syndrome (WKS), which causes specific brain damage.